Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TIA, stroke, and mitral valve prolapse.

R T Watson

    Neurology
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Mitral valve prolapse is linked to ischemic events like transient ischemic attacks and strokes. Sodium warfarin therapy showed promise in preventing recurrence, unlike aspirin.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diversity without representation.

    Nature·2006
    Same author

    A rodent model for investigating the neurobiology of contralateral neglect.

    Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology·2004
    Same author

    Tensilon and the diagnosis of myasthenia gravis: are we using the Tensilon test too much?

    The neurologist·2003
    Same author

    Subcellular compartmentalization and trafficking of the insulin-responsive glucose transporter, GLUT4.

    Experimental cell research·2001
    Same author

    Insulin stimulates actin comet tails on intracellular GLUT4-containing compartments in differentiated 3T3L1 adipocytes.

    The Journal of biological chemistry·2001
    Same author

    Asystole induced by edrophonium following beta blockade.

    Neurology·2001
    Same journal

    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

    Neurology·2026
    Same journal

    Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

    Neurology·2026
    Same journal

    Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

    Neurology·2026
    Same journal

    Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

    Neurology·2026
    Same journal

    Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

    Neurology·2026
    Same journal

    At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

    Neurology·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Neurology
    • Vascular Medicine

    Background:

    • Mitral valve prolapse (MVP) is a common cardiac condition.
    • Cerebrovascular events, including transient ischemic attacks (TIAs) and strokes, can occur in patients with MVP.
    • The underlying mechanisms linking MVP to ischemic events require further elucidation.

    Observation:

    • This report details eight patients experiencing TIAs and three with partial nonprogressive strokes.
    • These ischemic events were associated with diagnosed mitral valve prolapse.
    • No alternative causes for the observed ischemic events were identified in these patients.

    Findings:

    • A single episode of ischemia recurred in one patient during aspirin treatment.
    • No ischemic recurrences were observed in patients treated with sodium warfarin therapy.

    Related Experiment Videos

  • Sodium warfarin demonstrated a potential protective effect against recurrent ischemia in this cohort.

    • Implications:

    • These findings suggest a potential role for anticoagulation in managing ischemic complications of MVP.
    • Further research is warranted to confirm the efficacy and safety of sodium warfarin in this patient population.
    • Identifying and managing MVP-associated cerebrovascular risks may improve patient outcomes.